Virtual reality tests for age-related macular degeneration
Part of Eyes & vision clinical trials.
This study tests whether virtual reality tests can measure vision problems caused by age-related macular degeneration (AMD). It includes people with different stages of AMD, from early to advanced, as well as healthy adults, to see how well the tests work for each group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years old or older.
- You must be able to understand and speak French well enough to follow study instructions.
- You must be able to give informed consent and follow the study protocol.
- You must be covered by French Social Security.
- Your eyes need to be clear and open wide enough for good images, as determined by the study doctor.
- Depending on the group, you either need healthy vision or a confirmed diagnosis of AMD (including early, intermediate, or atrophic types).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special vision test called microperimetry to track how well the macula (the center of the retina) works in people with certain eye conditions like geographic atrophy or diabetic eye disease. Healthy volunteers are also needed for comparison. The goal is to understand how these conditions affect retinal function over time.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
This study tests a quick, noninvasive eye test that measures how well you see in the dark, which can be an early sign of dry AMD. Researchers want to see if the test relates to everyday tasks like reading or driving at night.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
Hear when a new Geographic Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.